(Q35843398)

10 August 2017

Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis (English)

1 reference

10 August 2017

1 reference

9

Dominique Heymann

1 reference

10 August 2017

Eva Grimaud

1

1 reference

10 August 2017

Luc Soubigou

2

1 reference

10 August 2017

Séverine Couillaud

3

1 reference

10 August 2017

Patrick Coipeau

4

1 reference

10 August 2017

Anne Moreau

5

1 reference

10 August 2017

Norbert Passuti

6

1 reference

10 August 2017

François Gouin

7

1 reference

10 August 2017

Françoise Redini

8

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

The American Journal of Pathology

10 August 2017

1 reference

10 August 2017

163

1 reference

10 August 2017

5

1 reference

10 August 2017

2021-2031

1 reference

describes a project that uses

10 August 2017

ImageQuant

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC1892410/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Receptor activator of NF-kappaB ligand (RANKL) is expressed in chondroblastoma: possible involvement in osteoclastic giant cell recruitment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

27 July 2018

Osteolysis and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

Osteoprotegerin and rank ligand expression in prostate cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

Molecular mechanisms of osteolytic bone metastases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

Wear Debris in Total Joint Replacements

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

Cancer cells responsible for humoral hypercalcemia express mRNA encoding a secreted form of ODF/TRANCE that induces osteoclast formation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

Tumour cells produce receptor activator of NF-kappaB ligand (RANKL) in skeletal metastases

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

RANK-L and RANK: T cells, bone loss, and mammalian evolution

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

Molecular basis of the spectrum of skeletal complications of neoplasia

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

24 September 2018

Giant-cell tumor of bone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892410

gp130 Cytokine family and bone cells

24 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963560-2

Breast cancer cells interact with osteoblasts to support osteoclast formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963560-2

Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963560-2

Immunohistochemical study of receptor activator of nuclear factor kappa-B ligand (RANK-L) in human osteolytic bone tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963560-2

RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963560-2

Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963560-2

Osteoprotegerin differentially regulates protease expression in osteoclast cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963560-2

TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963560-2

Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963560-2

Osteoprotegerin: a new therapeutic agent for the treatment of bone disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963560-2

7 January 2021

inferred from DOI database lookup

[Natural history and development of bone metastasis. Apropos of 429 cases]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14578201

12 December 2020

inferred from PubMed ID database lookup

Serum osteoprotegerin levels in healthy controls and cancer patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14578201

12 December 2020

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/14578201

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1016/S0002-9440(10)63560-2

1 reference

10 August 2017

1 reference

10 August 2017

1 reference